O&G · Gynaecological health — menstrual disorders
Dysmenorrhoea and the PMS–PMDD spectrum: prostaglandin-mediated period pain and the luteal-phase psychiatric disorder
Also known as Dysmenorrhoea · Primary dysmenorrhoea · Secondary dysmenorrhoea · Premenstrual syndrome · PMS · Premenstrual dysphoric disorder · PMDD
Exam-exhaustive FRANZCOG fellowship topic on dysmenorrhoea and the premenstrual syndrome to premenstrual dysphoric disorder spectrum: primary dysmenorrhoea (prostaglandin-mediated, with the COX-PGF2α pathway read from source), secondary dysmenorrhoea (endometriosis, adenomyosis, fibroids, copper IUD), the PMS/PMDD spectrum with DSM-5 PMDD criteria reproduced verbatim, the symptom-free follicular phase signature, and the evidence-based management ladder (NSAID, COCP/progestin, LNG-IUS, SSRI continuous or luteal-phase, CBT, GnRH). RANZCOG-primary, globally tagged to MRCOG, ABOG, FRCSC and MRCPI.
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- Dysmenorrhoea that fails to respond to 3–6 months of adequate first-line therapy — investigate for a secondary cause (endometriosis, adenomyosis, submucous fibroid)
- Dysmenorrhoea developing years after menarche and progressively worsening — secondary until proven otherwise
- Severe dyspareunia, deep pain, abnormal bleeding or a pelvic mass — exclude endometriosis, adenomyosis or malignancy
- Suicidal ideation in a woman with premenstrual symptoms — escalate to psychiatric assessment now; PMDD carries a substantial suicide risk
- A woman with cyclical mood symptoms and a personal or family history of bipolar disorder — SSRIs can destabilise mood; psychiatry liaison first
- Acute severe pelvic pain with syncope, fever or peritonism — exclude ectopic pregnancy, torsion or pelvic inflammatory disease before attributing to dysmenorrhoea
A 16-year-old misses school every month with cramping pain, and a 34-year-old dreads the week before her period because she becomes a person she does not recognise. The first has primary dysmenorrhoea; the second has PMDD. The two sit on the same clinic list because both are driven by the menstrual cycle — and both are under-recognised, under-treated and examinable. This topic covers the prostaglandin pathway of primary dysmenorrhoea, the causes of secondary dysmenorrhoea, the DSM-5 PMDD criteria reproduced verbatim, and the evidence behind every step of the ladder.[1][6][8]
Overview and definition
Dysmenorrhoea is painful menstrual cramping of uterine origin. It is the most common menstrual complaint and, in up to 20% of women, is severe enough to interfere with daily activities.[6]
- Primary dysmenorrhoea — painful menstruation in the absence of pelvic pathology. It usually begins within 6 to 12 months of menarche, with spasmodic cramping lower abdominal pain starting just before or at the onset of menstruation and peaking in the first 24 to 72 hours, often with nausea, vomiting, diarrhoea, fatigue and headache.[6][7]
- Secondary dysmenorrhoea — dysmenorrhoea associated with an organic or structural cause. It develops years after menarche (often in the third or fourth decade), is frequently progressive, may begin days before menses, and is accompanied by other features of the underlying disease (dyspareunia, abnormal bleeding, subfertility).[6]
The premenstrual disorders occupy a separate but adjacent spectrum, defined by timing: psychological and physical symptoms that develop in the luteal phase, cause functional impairment, and resolve shortly after the onset of menses. They are subdivided into premenstrual syndrome (PMS) and the more severe premenstrual dysphoric disorder (PMDD).[8][10]
Why this matters — the burden in numbers
References15ShowHide
- [1]Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev, 2015.PMID 26224322
- [2]Dawood MY Dysmenorrhoea and prostaglandins: pharmacological and therapeutic considerations. Drugs, 1981.PMID 6790261
- [3]Dawood MY Nonsteroidal anti-inflammatory drugs and changing attitudes toward dysmenorrhea. Am J Med, 1988.PMID 3287908
- [4]Smith CA, Armour M, Zhu X, et al. Acupuncture for dysmenorrhoea. Cochrane Database Syst Rev, 2016.PMID 27087494
- [5]Pattanittum P, Kunyanone N, Brown J, et al. Dietary supplements for dysmenorrhoea. Cochrane Database Syst Rev, 2016.PMID 27000311
- [6]Latthe PM, Champaneria R, Khan KS Dysmenorrhoea. BMJ Clin Evid, 2011.PMID 21718556
- [7]American College of Obstetricians and Gynecologists' Committee on Adolescent Health Care ACOG Committee Opinion No. 760: Dysmenorrhea and Endometriosis in the Adolescent. Obstet Gynecol, 2018.PMID 30461694
- [8]Hofmeister S, Bodden S Premenstrual Syndrome and Premenstrual Dysphoric Disorder. Am Fam Physician, 2016.PMID 27479626
- [9]Marjoribanks J, Brown J, O'Brien PM, Wyatt K Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev, 2013.PMID 23744611
- [10]O'Brien PM, Bäckström T, Brown C, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health, 2011.PMID 21225438
- [11]Nevatte T, O'Brien PM, Bäckström T, et al. ISPMD consensus on the management of premenstrual disorders. Arch Womens Ment Health, 2013.PMID 23624686
- [12]Ismaili E, Walsh S, O'Brien PMS, et al. Fourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder. Arch Womens Ment Health, 2016.PMID 27378473
- [13]Endicott J, Nee J, Harrison W Daily Record of Severity of Problems (DRSP): reliability and validity. Arch Womens Ment Health, 2006.PMID 16172836
- [14]Lanza di Scalea T, Pearlstein T Premenstrual Dysphoric Disorder. Psychiatr Clin North Am, 2017.PMID 28477648
- [15]Lanza di Scalea T, Pearlstein T Premenstrual Dysphoric Disorder. Med Clin North Am, 2019.PMID 31078196